Literature DB >> 6469957

Structure of the N-asparagine-linked oligosaccharide units of human placental beta-glucocerebrosidase.

S Takasaki, G J Murray, F S Furbish, R O Brady, J A Barranger, A Kobata.   

Abstract

The N-asparagine-linked oligosaccharide chains of homogeneous human placental beta-glucocerebrosidase were released by hydrazinolysis, and their structures were analyzed. The sequence of sugars, linkage, and anomeric configuration of the glycosidic bonds were determined. Approximately 20% of the released sugar chain was of the typical high mannose type. The balance was of complex type with biantennary and triantennary structures. As a major component, the following trisialylated oligosaccharide was detected: (formula; see text).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Lessons learned from the development of enzyme therapy for Gaucher disease.

Authors:  J A Barranger; E O'Rourke
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease.

Authors:  Jie Lu; Chunzhang Yang; Masako Chen; Donald Y Ye; Russell R Lonser; Roscoe O Brady; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Recombinant human acid beta-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts.

Authors:  Serena Reggi; Stefano Marchetti; Tamara Patti; Francesca De Amicis; Roberta Cariati; Bruno Bembi; Corrado Fogher
Journal:  Plant Mol Biol       Date:  2005-01       Impact factor: 4.076

4.  The studies on substrate, product and inhibitor binding to a wild-type and neuronopathic form of human acid-beta-glucosidase.

Authors:  Igor Z Zubrzycki; Agnieszka Borcz; Magdalena Wiacek; Wojciech Hagner
Journal:  J Mol Model       Date:  2007-08-23       Impact factor: 1.810

Review 5.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

6.  Overexpression of human glucocerebrosidase containing different-sized leaders.

Authors:  M Pasmanik-Chor; O Elroy-Stein; H Aerts; V Agmon; S Gatt; M Horowitz
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

Review 7.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

Review 8.  Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.

Authors:  R O Brady; G J Murray; N W Barton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.

Authors:  Y Sato; E Beutler
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.